3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
4
Withdrawn
1
Unknown
1
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neoplasms
2
Neoplasm Metastasis
2
Colorectal Neoplasms
2
Uveal Melanoma
1
Sarcoma
1
Pancreatic Neoplasms
1
Neurofibromatosis 2
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Macular Degeneration
1
Lung Neoplasms
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Colorectal Cancer Metastatic
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Capecitabine
3
Fluorouracil
2
Cetuximab
2
Bevacizumab
2
aflibercept
1
Panitumumab
1
Oxaliplatin
1
Nivolumab
1
Methotrexate
1
Leucovorin
1
Hypnosis
1
Celecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Colorectal Cancer Metastatic
×
aflibercept
×
Clear all
NCT01955629
2016-04-18
AMOR
Sanofi
Phase 1/2
Terminated
4 enrolled
7 charts